Marketresearch.biz reports that the The End stage Renal Disease Market size is predicted to reach approximately USD 391.8 Bn by 2032, from a valuation of USD 98.6 Bn in 2022, growing at a CAGR of 15.2% during the forecast period from 2023 to 2032.Overview of the End Stage Renal Disease MarketThe End Stage Renal Dise.
Marketresearch.biz reports that the The global Personalized Medicine Biomarkers Market was valued at USD 15.5 Billion in 2022. It is expected to reach USD 67.6 Billion by 2032, with a CAGR of 16.3% during the forecast period from 2023 to 2032.Overview of the Personalized Medicine Biomarkers MarketThe Personalized Me.